These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26851630)

  • 1. Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathway.
    Li Z; You K; Li J; Wang Y; Xu H; Gao B; Wang J
    Int Immunopharmacol; 2016 Apr; 33():24-32. PubMed ID: 26851630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
    Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
    Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1/2-COX-2 signaling.
    Li F; Zhu YT
    Cell Signal; 2015 Apr; 27(4):860-6. PubMed ID: 25643632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis.
    Rhee H; Kim HY; Choi JH; Woo HG; Yoo JE; Nahm JH; Choi JS; Park YN
    Cancer Res; 2018 Apr; 78(7):1619-1631. PubMed ID: 29363547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
    Schmidt CM; Wang Y; Wiesenauer C
    J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.
    Park JW; Park JE; Lee JA; Lee CW; Kim CM
    J Cancer Res Clin Oncol; 2006 Mar; 132(3):184-92. PubMed ID: 16331492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
    Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production.
    Zhao Y; Sun Y; Zhang H; Liu X; Du W; Li Y; Zhang J; Chen L; Jiang C
    Int J Clin Exp Pathol; 2015; 8(4):3719-26. PubMed ID: 26097553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgolic acid suppresses the invasion of HepG2 cells via downregulation of HGF/c‑Met signaling.
    Li H; Meng X; Zhang D; Xu X; Li S; Li Y
    Oncol Rep; 2019 Jan; 41(1):369-376. PubMed ID: 30320342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
    Shi MD; Liao YC; Shih YW; Tsai LY
    Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials.
    Li Y; Huang X; Zhang Q; Ma K
    Mol Med Rep; 2013 Aug; 8(2):655-61. PubMed ID: 23778885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.
    Ogunwobi OO; Liu C
    Clin Exp Metastasis; 2011 Dec; 28(8):721-31. PubMed ID: 21744257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.
    Gao F; Deng G; Liu W; Zhou K; Li M
    Oncol Rep; 2017 Feb; 37(2):1203-1211. PubMed ID: 28075467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.